Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study

Patients (n = 34) with previously untreated, slowly progressive asymptomatic stage I/II multiple myeloma or with stage II/III multiple myeloma in stable response/plateau phase following conventional anti-tumor therapy were immunized repeatedly with the antigen-specific cancer immunotherapeutic agent...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hum Vaccin Immunother
Main Authors: Rossmann, Eva, Österborg, Anders, Löfvenberg, Eva, Choudhury, Aniruddha, Forssmann, Ulf, von Heydebreck, Anja, Schröder, Andreas, Mellstedt, Håkan
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2014
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514088/
https://ncbi.nlm.nih.gov/pubmed/25483677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29918
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker